Gilead Sciences Inc.

NAS : GILD
Pharmaceuticals
Foster City CA
Revenue (US$ Millions)$24,890
Revenue Growth (%)122.20%
Net Income (Millions)$12,101
Common Shares Outstanding (Millions)$1,499
Earnings per Share$7.35
Price To Earnings Ratio14.37
Total Equity (Millions)$15,426
Profit Margin 148.62%
Return on Equity106.44%
Long Term Debt (US$ Millions)$11,921
Debt To Equity Ratio (%)0.77%
Market Capitalization (US$ Millions)$141,296
Total Assets (US$ Millions)$34,664
Return on Assets (%)53.79
Current Assets (US$ Millions)$17,714
Inventories (US$ Millions)$1,386
Current Liabilities (US$ Millions)$5,761
Cost of Goods Sold (US$ Millions)$3,788
Asset Turnover0.72
Inventory Turnover2.2